TPX2 as a prognostic biomarker and potential therapeutic target for malignant melanoma proliferation and metastasis
Experimental and Therapeutic Medicine · 08.05.2026 · 32 (1) · 1-10
DOI: 10.3892/etm.2026.13177 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental and Therapeutic Medicine, online erschienen am 08.05.2026. Verfasst von Fuqi Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: The First School of Clinical Medicine, Guangdong Medical University, Zhanjiang, Guangdong 524023, P.R. China. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First School of Clinical Medicine, Guangdong Medical University, Zhanjiang, Guangdong 524023, P.R. China.
- Department of Plastic Surgery, Maoming People's Hospital, Maoming, Guangdong 525000, P.R. China.
- Department of Burn Surgery, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524013, P.R. China.
Zitieren
APA
Li, F., Yang, R., & Wu, Z. (2026). TPX2 as a prognostic biomarker and potential therapeutic target for malignant melanoma proliferation and metastasis. Experimental and Therapeutic Medicine, 32(1), 1-10. https://doi.org/10.3892/etm.2026.13177
Vancouver
Li F, Yang R, Wu Z. TPX2 as a prognostic biomarker and potential therapeutic target for malignant melanoma proliferation and metastasis. Experimental and Therapeutic Medicine. 2026;32(1):1-10. doi:10.3892/etm.2026.13177
BibTeX
@article{Li2026,
author = {Li, Fuqi and Yang, Ronghui and Wu, Zhixian},
title = {TPX2 as a prognostic biomarker and potential therapeutic target for malignant melanoma proliferation and metastasis},
journal = {Experimental and Therapeutic Medicine},
year = {2026},
volume = {32},
number = {1},
pages = {1--10},
doi = {10.3892/etm.2026.13177}
}
EUVIMED